Phase 3 trial data confirm efficacy and safety profile of R21/Matrix-M malaria vaccine in African children Read more
GSK and Oxford University announce Oxford-GSK Institute of Molecular and Computational Medicine Read more
AstraZeneca says COVID-19 vaccine 76 per cent effective in new analysis, to seek US approval Read more